Evaluation of inhaled antimicrobials as adjunctive therapy in the treatment of ventilator-associated pneumonia
Abstract
Nebulized antibiotics show notable efficacy owing to their significant local concentrations and provide safety with low blood levels. In addition to these measurements, duration of hospitalization, ICU stay, days used to administer antibiotics, days on mechanical ventilation, days without mechanical ventilation, days until clinical cure, and mortality rate were used to evaluate effectiveness. Nephrotoxicity was significantly lowered in the nebulized group due to the significant preservation of kidney functionality.
To assess the role of inhaled antimicrobials as an adjunctive treatment in the therapy of ventilator-associated pneumonia (VAP).
In this case–control prospective study, 70 patients with VAP were admitted to respiratory ICU at Abbassia Chest Disease Hospital between September 2018 and September 2019.
Univariate logistic regression analysis revealed that significant predictors correlated with resolution of VAP were age less than or equal to 53 years [P=0.031; odds ratio (OR): 3.474, confidence interval (CI): 1.121–10.763] and duration of mechanical ventilation less than or equal to 11 days (P=0.022; OR: 3.778, CI: 1.215–11.746), while on multivariate logistic regression analysis, duration of mechanical ventilation less than or equal to 11 days was the most significant predictor for the resolution of VAP (P=0.040; OR: 3.396, CI: 1.058–10.905).
Based on our findings, treatment with inhaled antibiotics was associated with significantly higher incidence of VAP…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.